|
CVAC Systems, Inc. has produced several prototypes of our unique global patent-pending technology for use in research and fitness application pilot projects. We have assembled a world-class management team and have attracted an outstanding group of investors.
To date, four formal scientific review boards have determined that the Cyclic Variations in Altitude Conditioning™ technology poses no significant risk. The Institutional Review Board at Stanford University has authorized researchers at the Veterans Affairs Palo Alto Health Care System (VAPAHCS) to study the use of the CVAC™ process with individuals up to 70 years old representing a wide array of health statuses.
CVAC Systems, Inc.’s primary focus is researching the potential of the CVAC process in insulin resistance, metabolic syndrome and diabetes. We are maintaining our long-time interest in the CVAC process and human performance.
A wide variety of CVAC users from World Champion athletes to seniors have used the CVAC process, resulting in remarkable testimonials. Initial scientific validation data produced by researchers at the University of Hawaii and the pilot study data from Stanford University/VAPAHCS corroborate with testimonials from CVAC users. This body of evidence supports our belief that the CVAC process represents a breakthrough platform technology.
We invite you to join with us in exploring this technology through the information contained in this website, active discussions and in person.
Sincerely,
|
| |
| |
What's New
Veterans Medical Research Foundation, Veterans Affairs (VA) San Diego Healthcare System and CVAC Systems, Inc. Sign Cooperative Research and Development Agreement
view news release
The Doctors TV Show Discusses Potential Role of the CVAC Process in Reducing Diabetes Risk
view news release
Stanford University and Veterans Affairs Researchers Demonstrate Significant Glucose Reduction in Study of CVAC Process for Insulin Resistance and Diabetes
view news release
CVAC Systems and TempusClinic partner to study the potential value of the CVAC process in managing and treating diabetes, insulin resistance, and metabolic syndrome
view news release
CVAC Systems Invited by Dow Jones to Present its Unique Platform Technology at Emerging Ventures Conference
view news release
CVAC Systems Expands Scientific Advisory Board, and Initiates Investigations into Diabetes, Insulin Resistance, and Metabolic Syndrome Applications
view news release
• News Release Archives
|
|
|
